• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Biostatistical basis of elective node dissection for malignant melanoma.恶性黑色素瘤选择性淋巴结清扫术的生物统计学基础
Ann Surg. 1977 Jul;186(1):101-3. doi: 10.1097/00000658-197707000-00014.
2
Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage).肢体恶性黑色素瘤:一项采用侵袭水平(微分期)的临床病理研究
Cancer. 1975 Mar;35(3):666-76. doi: 10.1002/1097-0142(197503)35:3<666::aid-cncr2820350320>3.0.co;2-4.
3
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.肢体I期黑色素瘤即刻淋巴结清扫术的无效性
N Engl J Med. 1977 Sep 22;297(12):627-30. doi: 10.1056/NEJM197709222971202.
4
Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow).根据微浸润深度选择I期黑色素瘤的最佳手术治疗方法:联合微分期技术(克拉克-布雷斯洛法)的应用
Ann Surg. 1975 Sep;182(3):302-15. doi: 10.1097/00000658-197509000-00013.
5
Microstages in malignant melanoma--the basis for an elective lymph node dissection.恶性黑色素瘤的微分期——选择性淋巴结清扫的基础
J Cancer Res Clin Oncol. 1980;96(3):303-9. doi: 10.1007/BF00408103.
6
Selective use of wide excision with elective lymph node dissection for malignant melanoma.选择性广泛切除联合选择性淋巴结清扫术治疗恶性黑色素瘤。
Pathol Annu. 1985;20 Pt 1:239-46.
7
Regional lymph node metastases and the level of invasion of primary melanoma.区域淋巴结转移及原发性黑色素瘤的浸润程度。
Cancer. 1976 Jan;37(1):199-201. doi: 10.1002/1097-0142(197601)37:1<199::aid-cncr2820370128>3.0.co;2-l.
8
A rational approach to the surgical management of melanoma.一种合理的黑色素瘤手术治疗方法。
Ann Surg. 1977 Oct;186(4):481-90. doi: 10.1097/00000658-197710000-00010.
9
Characteristics of the primary lesion of malignant melanoma as a guide to prognosis and therapy.恶性黑色素瘤原发损害的特征作为预后和治疗的指导
Ann Surg. 1979 Feb;189(2):225-35. doi: 10.1097/00000658-197902000-00015.
10
The surgical approach to primary malignant melanoma.原发性恶性黑色素瘤的手术治疗方法。
Surg Gynecol Obstet. 1985 Apr;160(4):379-86.

引用本文的文献

1
Lymph node dissection for melanoma: where do we stand?黑色素瘤的淋巴结清扫术:我们目前的情况如何?
Melanoma Manag. 2017 Mar;4(1):49-59. doi: 10.2217/mmt-2016-0023. Epub 2017 Mar 3.
2
Importance of sentinel lymph node biopsy in patients with thin melanoma.前哨淋巴结活检在薄型黑色素瘤患者中的重要性。
Arch Surg. 2008 Sep;143(9):892-9; discussion 899-900. doi: 10.1001/archsurg.143.9.892.
3
A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire.对接受新城疫病毒(NDV)溶瘤产物术后治疗的美国癌症联合委员会(AJCC)III期恶性黑色素瘤患者进行15年随访,并确定CD8 T细胞库的变化。
Mol Med. 1998 Dec;4(12):783-94.
4
[Axillary recurrence after lymph node excision in malignant melanoma].[恶性黑色素瘤淋巴结切除术后腋窝复发]
Langenbecks Arch Chir. 1993;378(1):4-11. doi: 10.1007/BF00207987.
5
Microstages in malignant melanoma--the basis for an elective lymph node dissection.恶性黑色素瘤的微分期——选择性淋巴结清扫的基础
J Cancer Res Clin Oncol. 1980;96(3):303-9. doi: 10.1007/BF00408103.
6
Diagnosis, treatment and prognosis of early melanoma. The importance of depth of microinvasion.早期黑色素瘤的诊断、治疗与预后。微浸润深度的重要性。
Ann Surg. 1980 Jan;191(1):87-97. doi: 10.1097/00000658-198001000-00017.
7
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).黑色素瘤的多因素分析:III. 有淋巴结转移的黑色素瘤患者(II期)的预后因素
Ann Surg. 1981 Mar;193(3):377-88. doi: 10.1097/00000658-198103000-00023.
8
Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes.恶性黑色素瘤扩散至区域淋巴结患者生存的预后因素。
Ann Surg. 1982 Jul;196(1):69-75. doi: 10.1097/00000658-198207000-00015.
9
A prospective randomized study of regional extremity perfusion in patients with malignant melanoma.一项针对恶性黑色素瘤患者肢体区域灌注的前瞻性随机研究。
Ann Surg. 1984 Dec;200(6):764-8. doi: 10.1097/00000658-198412000-00016.
10
Prognosis of patients with pathologic stage II cutaneous malignant melanoma.病理II期皮肤恶性黑色素瘤患者的预后
Ann Surg. 1985 Jan;201(1):103-7.

本文引用的文献

1
Method of analysis for evaluation of treatment in cancer of the oropharynx.口咽癌治疗评估的分析方法
Radiology. 1962 May;78:783-9. doi: 10.1148/78.5.783.
2
REGIONAL LYMPH NODE DISSECTION AND MALIGNANT MELANOMA. EFFECT OF SURVIVAL.区域淋巴结清扫与恶性黑色素瘤。对生存的影响。
Arch Surg. 1963 Nov;87:747-50. doi: 10.1001/archsurg.1963.01310170033007.
3
The role of radical regional lymphadenectomy in treatment of melanoma.根治性区域淋巴结清扫术在黑色素瘤治疗中的作用。
Am J Surg. 1962 Aug;104:135-42. doi: 10.1016/0002-9610(62)90314-8.
4
The histogenesis and biologic behavior of primary human malignant melanomas of the skin.原发性人类皮肤恶性黑色素瘤的组织发生及生物学行为
Cancer Res. 1969 Mar;29(3):705-27.
5
Selective regional lymphadenectomy for melanoma: a mathematical aid to clinical judgment.黑色素瘤的选择性区域淋巴结清扫术:临床判断的数学辅助手段
Ann Surg. 1971 Sep;174(3):402-13. doi: 10.1097/00000658-197109000-00009.
6
Treatment of malignant melanoma: wide excision alone vs lymphadenectomy.恶性黑色素瘤的治疗:单纯广泛切除与淋巴结清扫术的比较
Arch Surg. 1972 Apr;104(4):587-93. doi: 10.1001/archsurg.1972.04180040201034.
7
Results of regional lymph node dissection for melanoma.黑色素瘤区域淋巴结清扫的结果。
Ann Surg. 1974 Jan;179(1):105-8. doi: 10.1097/00000658-197401000-00020.
8
Studies concerning the regional lymph node in cancer. IV. Tumor inhibition by regional lymph node cells.关于癌症区域淋巴结的研究。IV. 区域淋巴结细胞对肿瘤的抑制作用。
Cancer. 1974 Mar;33(3):631-6. doi: 10.1002/1097-0142(197403)33:3<631::aid-cncr2820330307>3.0.co;2-g.
9
The role of groin dissection in the management of melanoma of the lower extremity.腹股沟淋巴结清扫术在下肢黑色素瘤治疗中的作用。
Ann Surg. 1974 Feb;179(2):156-9. doi: 10.1097/00000658-197402000-00007.
10
Should lymphadenectomy be discarded? I. Immunological considerations.淋巴结切除术应该被摒弃吗?I. 免疫学考量
J R Coll Surg Edinb. 1973 Nov;18(6):351-6.

恶性黑色素瘤选择性淋巴结清扫术的生物统计学基础

Biostatistical basis of elective node dissection for malignant melanoma.

作者信息

Fortner J G, Woodruff J, Schottenfeld D, Maclean B

出版信息

Ann Surg. 1977 Jul;186(1):101-3. doi: 10.1097/00000658-197707000-00014.

DOI:10.1097/00000658-197707000-00014
PMID:879870
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1396205/
Abstract

During the years 1954 through 1964, 259 individuals with primary malignant melanoma had an elective node dissection. Microscopic metastases were found in 15% of these patients. The presence of only a microscopic focus of involvement gave a 10-year cure rate of 67%; metastasis larger than a microscopic focus in a single node, 50%; and more than one node, 15%. One hundred forty-five individuals were treated by wide excision alone with 18% subsequently requiring a therapeutic lymphadenectomy with a ten-year cure of only 6%. A prospective study was then initiated which was concerned with efficacy of selection of patients for elective node dissection. Clark's level of invasion was determined for 258 patients treated since January 1972. The depth of invasion of the primary lesion was found to correlate directly with the absence of lymph node metastases, extent of nodal involvement, and rate of recurrence. It is concluded that the concept of elective node dissection is valid.

摘要

在1954年至1964年期间,259例原发性恶性黑色素瘤患者接受了选择性淋巴结清扫术。其中15%的患者发现有微小转移灶。仅存在微小受累灶的患者10年治愈率为67%;单个淋巴结中转移灶大于微小病灶的患者治愈率为50%;多个淋巴结受累的患者治愈率为15%。145例患者仅接受了广泛切除术,其中18%的患者随后需要进行治疗性淋巴结清扫术,其10年治愈率仅为6%。随后开展了一项前瞻性研究,关注选择性淋巴结清扫术患者选择的有效性。对自1972年1月以来接受治疗的258例患者确定了克拉克侵袭水平。发现原发性病变的侵袭深度与无淋巴结转移、淋巴结受累程度和复发率直接相关。结论是选择性淋巴结清扫术的概念是有效的。